The COVID-19 pandemic put tremendous pressure on drug-development organizations to accelerate product development far beyond anyone’s wildest roadmaps. “The fast-track part [of producing COVID-19 vaccines] were regulatory approvals, funding, data analysis and submission to the FDA (Food and Drug Administration). Those are all paperwork items. What was not
Buy this Book to learn exactly what it takes to deliver personalized experiences at scale.
Get exclusive access to Val’s thoughts and hand-picked content with our newsletter.
“*” indicates required fields